(Total Views: 668)
Posted On: 03/28/2025 3:57:02 PM
Post# of 155794
"Glioblastoma outbreaks...wonder how LL could help...it def can't until it's approved, though..."
Dr Chan is still in the fight. They (Cytodyn) need to figure out how to increase receptor occupancy north of the Blood Brain Barrier (I read, somewhere, that it's around 70% occupancy). However, Dr Chan has been on it for nine months. He has a very aggressive type of Glioblastoma. At the very least, I think Leronlimab is helping to keep the cancer from being as aggressive. Additionally, he has not had metastasis to anywhere else. I wonder if they have checked for Circulating Tumor Cells? He drinks a beer every now and then. He is enjoying time with his family. I think Leronlimab is responsible for his other treatments not destroying his quality of life (keeping his immune system regulated, keeping inflammation under control, displacing some of the bad side effects of the other treatments). I think this is the very least that Leronlimab can help. Depending on what biomarkers are tracked, and the information Cytodyn gets. Our team should have a beneficial start to a clinical protocol.
Dr Chan is still in the fight. They (Cytodyn) need to figure out how to increase receptor occupancy north of the Blood Brain Barrier (I read, somewhere, that it's around 70% occupancy). However, Dr Chan has been on it for nine months. He has a very aggressive type of Glioblastoma. At the very least, I think Leronlimab is helping to keep the cancer from being as aggressive. Additionally, he has not had metastasis to anywhere else. I wonder if they have checked for Circulating Tumor Cells? He drinks a beer every now and then. He is enjoying time with his family. I think Leronlimab is responsible for his other treatments not destroying his quality of life (keeping his immune system regulated, keeping inflammation under control, displacing some of the bad side effects of the other treatments). I think this is the very least that Leronlimab can help. Depending on what biomarkers are tracked, and the information Cytodyn gets. Our team should have a beneficial start to a clinical protocol.
(18)
(0)
